🚀 VC round data is live in beta, check it out!
Extendicare Valuation Multiples
Discover revenue and EBITDA valuation multiples for Extendicare and similar public comparables like Addus HomeCare, Sienna Senior Living, Attendo, Sonida Senior Living and more.
Extendicare Overview
About Extendicare
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The company has three main business segments namely Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada.
Founded
2012
HQ
Employees
24.0K
Website
Sectors
Financials (LTM)
EV
$2B
Extendicare Financials
Extendicare reported last 12-month revenue of $1B and EBITDA of $142M.
In the same LTM period, Extendicare generated $142M in EBITDA and $76M in net income.
Revenue (LTM)
Extendicare P&L
In the most recent fiscal year, Extendicare reported revenue of $1B and EBITDA of $136M.
Extendicare expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| EBITDA | $142M | XXX | $136M | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 8% | XXX | XXX | XXX |
| Net Profit | $76M | XXX | $71M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 6% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Extendicare Stock Performance
Extendicare has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Extendicare's stock price is $21.24.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | -2.1% | XXX | XXX | XXX | $0.75 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialExtendicare Valuation Multiples
Extendicare trades at 1.5x EV/Revenue multiple, and 14.1x EV/EBITDA.
EV / Revenue (LTM)
Extendicare Financial Valuation Multiples
As of April 18, 2026, Extendicare has market cap of $2B and EV of $2B.
Equity research analysts estimate Extendicare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Extendicare has a P/E ratio of 26.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 1.5x | XXX | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | 14.1x | XXX | 14.6x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 19.7x | XXX | XXX | XXX |
| P/E | 26.3x | XXX | 28.3x | XXX | XXX | XXX |
| EV/FCF | 50.3x | XXX | 26.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Extendicare Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Extendicare Margins & Growth Rates
Extendicare's revenue in the last 12 month grew by 24%.
Extendicare's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Extendicare's rule of 40 is 43% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Extendicare's rule of X is 92% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Extendicare Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 24% | XXX | 32% | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | 27% | XXX | 27% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 43% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 92% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | 81% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 91% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Extendicare Public Comps
See public comps and valuation multiples for other Long-Term Care comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Extendicare | XXX | XXX | XXX | XXX | XXX | XXX |
| Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Sienna Senior Living | XXX | XXX | XXX | XXX | XXX | XXX |
| Attendo | XXX | XXX | XXX | XXX | XXX | XXX |
| Sonida Senior Living | XXX | XXX | XXX | XXX | XXX | XXX |
| Clariane | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Extendicare M&A Activity
Extendicare acquired XXX companies to date.
Last acquisition by Extendicare was on XXXXXXXX, XXXXX. Extendicare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Extendicare
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialExtendicare Investment Activity
Extendicare invested in XXX companies to date.
Extendicare made its latest investment on XXXXXXXX, XXXXX. Extendicare invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Extendicare
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Extendicare
| When was Extendicare founded? | Extendicare was founded in 2012. |
| Where is Extendicare headquartered? | Extendicare is headquartered in Canada. |
| How many employees does Extendicare have? | As of today, Extendicare has over 24K employees. |
| Who is the CEO of Extendicare? | Extendicare's CEO is Michael R. Guerriere. |
| Is Extendicare publicly listed? | Yes, Extendicare is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Extendicare? | Extendicare trades under EXE ticker. |
| When did Extendicare go public? | Extendicare went public in 1974. |
| Who are competitors of Extendicare? | Extendicare main competitors are Addus HomeCare, Sienna Senior Living, Attendo, Sonida Senior Living. |
| What is the current market cap of Extendicare? | Extendicare's current market cap is $2B. |
| What is the current revenue of Extendicare? | Extendicare's last 12 months revenue is $1B. |
| What is the current revenue growth of Extendicare? | Extendicare revenue growth (NTM/LTM) is 24%. |
| What is the current EV/Revenue multiple of Extendicare? | Current revenue multiple of Extendicare is 1.5x. |
| Is Extendicare profitable? | Yes, Extendicare is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Extendicare? | Extendicare's last 12 months EBITDA is $142M. |
| What is Extendicare's EBITDA margin? | Extendicare's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of Extendicare? | Current EBITDA multiple of Extendicare is 14.1x. |
| What is the current FCF of Extendicare? | Extendicare's last 12 months FCF is $40M. |
| What is Extendicare's FCF margin? | Extendicare's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Extendicare? | Current FCF multiple of Extendicare is 50.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.